Lv64
1680 积分 2024-05-31 加入
miR-143-3p Promotes TSCM Differentiation and Inhibits Progressive T Cell Differentiation via Inhibiting ABL2 and PAG1
11天前
已完结
Features of HLA‐A*02 in Identifying Eligible Patients for Tecelra TCR‐T Therapy
11天前
已完结
Harnessing the Power of TCR-T Cell Therapy: A New Era in Cancer Immunotherapy
2个月前
已完结
Neoantigen-specific TCR-T cell therapy in advanced pancreatic cancer: a phase I clinical trial
2个月前
已关闭
Neoantigen-specific TCR-T cell therapy in advanced pancreatic cancer: a phase I clinical trial
2个月前
已关闭
From TCR fundamental research to innovative chimeric antigen receptor design
6个月前
已完结
Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma
6个月前
已完结
Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-engineered T cell-mediated antitumor activity
6个月前
已完结
In vivo CAR T cells move into clinical trials
7个月前
已完结
Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production
7个月前
已完结
皖公网安备34019202002308
